Un nuovo studio pubblicato sulla rivista Clinical Cancer Research mette in evidenza l’impiego del test EndoPredict per indicare quale trattamento adottare in pazienti con tumore al seno in premenopausa
31 août 2022 08h00 HE
|
Myriad Genetics, Inc.
Il test EndoPredict di Myriad Genetics ha identificato in modo accurato le donne in premenopausa con carcinoma mammario ER+, HER2- che potevano con sicurezza evitare la chemioterapia adiuvante SALT...
Neue Studie, im Clinical Cancer Research Journal veröffentlicht, unterstreicht die Bedeutung des EndoPredict-Tests zur Information über die Behandlung von prämenopausalen Brustkrebs-Patientinnen
31 août 2022 08h00 HE
|
Myriad Genetics, Inc.
Myriad Genetics’ EndoPredict-Test identifiziert präzise prämenopausale Frauen mit ER+, HER2-Brustkrebs, die eine adjuvante Chemotherapie vermeiden können SALT LAKE CITY, Aug. 31, 2022 (GLOBE...
Une nouvelle étude publiée dans le Clinical Cancer Research Journal met en avant l’utilisation du test EndoPredict pour éclairer les décisions thérapeutiques chez les patientes préménopausées atteintes d’un cancer du sein
31 août 2022 08h00 HE
|
Myriad Genetics, Inc.
Le test EndoPredict de Myriad Genetics identifie avec précision les femmes préménopausées atteintes d'un cancer du sein RE+, HER2- qui pourraient éviter une chimiothérapie adjuvante sans perte de...
New Study Published in Clinical Cancer Research Journal Highlights Use of EndoPredict Test to Inform Treatment for Premenopausal Breast Cancer Patients
31 août 2022 08h00 HE
|
Myriad Genetics, Inc.
Myriad Genetics’ EndoPredict test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid adjuvant chemotherapy SALT LAKE CITY, Aug. 31, 2022 (GLOBE NEWSWIRE)...
GENE Momentum building - a year in review
30 août 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in guideline driven genomics-based tests in health,...
Gene Amplification Technologies Global Market Report 2022: Advances in Genome Sequencing to Spur Industry Growth
25 août 2022 06h28 HE
|
Research and Markets
Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Gene Amplification Technologies - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Gene...
Precipio Launches New 1-Step Technology for all HemeScreen Assays
16 août 2022 11h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces the launch of its second generation of HemeScreen panels. Precipio’s...
Global Human Identification Market to Reach $6.43 Billion by 2032
04 août 2022 05h43 HE
|
Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "Human Identification - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region - Analysis and Forecast,...
Genetic Testing Global Market Report 2022:
02 août 2022 05h58 HE
|
Research and Markets
Dublin, Aug. 02, 2022 (GLOBE NEWSWIRE) -- The "Genetic Testing Market Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been added to...
Molecular Cytogenetics Global Market Report 2022-2026: Growing Demand for Targeted Therapies in Cancer Treatment Presents Lucrative Opportunities
29 juil. 2022 06h03 HE
|
Research and Markets
Dublin, July 29, 2022 (GLOBE NEWSWIRE) -- The "Molecular Cytogenetics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Molecular...